New cancer clinical trial: [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR)
Published on: October 30, 2018 at 11:00PM
Conditions: Breast Cancer; Prostate Cancer; Colorectal Cancer; Non Small Cell Lung Cancer; Small Cell Lung Cancer
Intervention: Drug: [68Ga]-NeoBOMB1
Sponsor: Advanced Accelerator Applications
Recruiting
https://ift.tt/2Q4PTsB [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR)
Conditions: Breast Cancer; Prostate Cancer; Colorectal Cancer; Non Small Cell Lung Cancer; Small Cell Lung Cancer
Intervention: Drug: [68Ga]-NeoBOMB1
Sponsor: Advanced Accelerator Applications
Recruiting
https://ift.tt/2Q4PTsB [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR)
Comments
Post a Comment